jtp 2942 has been researched along with pyrrolidonecarboxylic acid in 1 studies
| Studies (jtp 2942) | Trials (jtp 2942) | Recent Studies (post-2010) (jtp 2942) | Studies (pyrrolidonecarboxylic acid) | Trials (pyrrolidonecarboxylic acid) | Recent Studies (post-2010) (pyrrolidonecarboxylic acid) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 3,005 | 101 | 671 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deguchi, Y; Kimura, R; Kobayashi, T; Maeda, Y; Urayama, A; Yamada, S | 1 |
1 other study(ies) available for jtp 2942 and pyrrolidonecarboxylic acid
| Article | Year |
|---|---|
Brain receptor binding characteristics and pharmacokinetics of JTP-2942, a novel thyrotropin-releasing hormone (TRH) analogue.
Topics: Animals; Binding, Competitive; Brain; Dose-Response Relationship, Drug; Kinetics; Male; Membranes; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Receptors, Thyrotropin-Releasing Hormone; Substrate Specificity; Thyrotropin-Releasing Hormone; Tritium | 1999 |